Market research
6XC1.F Soleno Therapeutics, Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- 6
- Dividend yield
- 0.0%
- Beta
- 0.24
Community
Investor discussion
1 comment
Sign in to join the 6XC1.F discussion.
5 years, 5 months ago
Soleno Therapeutics, Inc is currently in a long term downtrend where the price is trading 38.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Soleno Therapeutics, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 80.5% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 35.2% to $-7M since the same quarter in the previous year.
Based on the above factors, Soleno Therapeutics, Inc gets an overall score of 2/5.